Lisata Therapeutics Stock Investor Sentiment

LSTA Stock  USD 2.26  0.07  3.00%   
About 61% of Lisata Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Lisata Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Lisata Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Lisata Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
over two months ago at prnewswire.com         
CRBU Investors with Losses in Excess of 100K Have Opportunity to Lead Caribou Biosciences, Inc. Secu...
prnewswire News
over two months ago at bizjournals.com         
Imbed Biosciences hires Bristol Myers Squibb veteran as CEO
bizjournals News
over two months ago at thelincolnianonline.com         
Revelation Biosciences, Inc. Short Interest Down 65.3 percent in December
news
over two months ago at prnewswire.com         
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635
prnewswire News
over two months ago at thefly.com         
Assembly Biosciences announces interim PK, efficacy from Phase 1b study ASMB
news
over two months ago at businesswire.com         
Rosen Law Firm Urges Caribou Biosciences, Inc. Investors to Contact the Firm for Information About T...
businesswire News
over two months ago at gurufocus.com         
Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating ...
Gurufocus Stories at Macroaxis
over two months ago at gurufocus.com         
Arcus Biosciences Inc Announces Equity Awards for New Employees
Gurufocus Stories at Macroaxis
over two months ago at simplywall.st         
Heres Why Were Watching Lisata Therapeutics Cash Burn Situation
Simply Wall St News at Macroaxis
over two months ago at prnewswire.com         
Keymed Biosciences gibt die Zulassung von Stapokibart fr die Behandlung von chronischer Rhinosinusit...
prnewswire News
over two months ago at finance.yahoo.com         
Castle Biosciences reports preliminary data from atopic dermatitis test study
Yahoo News
over two months ago at gurufocus.com         
Pulse Biosciences Inc Announces Redemption of Common Stock Warrants
Gurufocus Stories at Macroaxis
over two months ago at prnewswire.com         
Neurocrine Biosciences, Inc. Selects PANTHERxRare Specialty Pharmacy for Distribution of Crenessity
prnewswire News
over two months ago at gurufocus.com         
Castle Biosciences Highlights Progress for its Pipeline Atopic Dermatitis Gene Expression ...
Gurufocus Stories at Macroaxis
over two months ago at thefly.com         
Castle Biosciences provides update on AD gene expression profile test CSTL
news
Far too much social signal, news, headlines, and media speculation about Lisata Therapeutics that are available to investors today. That information is available publicly through Lisata media outlets and privately through word of mouth or via Lisata internal channels. However, regardless of the origin, that massive amount of Lisata data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Lisata Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Lisata Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Lisata Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Lisata Therapeutics alpha.

Lisata Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Lisata Stock analysis

When running Lisata Therapeutics' price analysis, check to measure Lisata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lisata Therapeutics is operating at the current time. Most of Lisata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lisata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lisata Therapeutics' price. Additionally, you may evaluate how the addition of Lisata Therapeutics to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
CEOs Directory
Screen CEOs from public companies around the world
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation